EU-X-CT – Patient Questionnaire – Borders should not be barriers to clinical trials
The EU-X-CT initiative aims at revolutionizing patient access to clinical trials across borders. But before we delve into the project details, we want to emphasize something crucial – your participation!
The data is being collected through a Patient Questionnaire which is available in multiple languages. Your insights are invaluable in understanding the current landscape of cross-border clinical trial access.
So, seize this opportunity to make your voice heard by completing the Patient Questionnaire. Remember, the deadline for submissions is March 5, 2024.
About the EU-X-CT Initiative
Led by a diverse coalition of stakeholders, EU-X-CT seeks to simplify the process of accessing clinical trials by gathering important data on cross-border access.
The initiative comprises three distinct task forces, each focusing on essential facets of cross-border access to clinical trials:
- Task Force 1 - Legal / Regulatory / Ethical
- Task Force 2 - Financial / Insurance
- Task Force 3 - People / Operational
Through extensive collaboration and data collection efforts, EU-X-CT aims to gain a comprehensive understanding of cross-border clinical trial access in European and non-European countries. By identifying existing barriers, we can pave the way for meaningful reforms that benefit patients, healthcare professionals, and regulatory authorities alike.
The EU-X-CT project represents a significant step forward in advancing patient-centered approaches to clinical trial access.